Successful preemptive therapy with single‐dose rituximab for Epstein‐Barr virus infection to prevent post‐transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Successful preemptive therapy with single‐dose rituximab for Epstein‐Barr virus infection to prevent post‐transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation

Authors:	Bo Kyung Kim Hyoung Jin Kang Kyung Taek Hong Hong Yul An Jung Yoon Choi Jee Soo Lee Sung Sup Park Hee Young Shin

Affiliation:	1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea;2. Seoul National University Cancer Research Institute, Seoul, Korea;3. https://orcid.org/0000-0003-1009-6002;4. Hyoung Jin Kang, Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, 101 Daehak‐ro, Jongno‐gu, Seoul 03722, Korea.;5. Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea;6. Department of Laboratory Medicine, Seoul National University, Seoul, Korea

Abstract:

Keywords:	Epstein‐Barr virus hematopoietic stem cell transplantation post‐transplant lymphoproliferative disease rituximab